검색어 : 통합검색[351.7]
총 2,652건 중 1,000건 출력
, 1/100 페이지
-
1
- A 307-fps 351.7-GOPs/W Deep Learning FPGA Accelerator for Real-Time Scene Text Recognition
- Zhao, Shirui; An, Fengwei; Yu, Hao; Southern University of Science and Technology; Southern University of Science and Technology; Southern University of Science and Technology; (Field-Programmable Technology (ICFPT), 2019 International Conference on, v.2019, 2019, pp.263-266)
-
2
- Far-infrared observations of G351.6 - 1.3/G351.7 - 1.2 region
- Ghosh, S. K.; Iyengar, K. V. K.; Rengarajan, T. N.; Tandon, S. N.; Verma, R. P.; Daniel, R. R.; ; (The Astrophysical journal, v.353, 1990, pp.564)
-
3
- Erratum: Formation of Fine Macrostructure in Ferritic Stainless Steel [Tetsu-to-Hagane Vol.98 (2012) No.7 p.351-357]
- Fukumoto, Shigeo; Kimura, Ken; Takahashi, Akihiko; ; (鐵と鋼 = Journal of the Iron and Steel Institute of Japan = Tetsu to hagane, v.98, 2012, pp.457-457)
-
4
- 351 nm, 0.7 ns laser damage thresholds of monomeric liquid-crystalline systems
- Papernov, S.; Marshall, K.; Guardalben, M.; Schmid, A.; Jacobs, S. D.; ; (Liquid crystals, v.9, 1991, pp.71-76)
-
5
- B.1.1.7 and B.1.351 SARS-CoV-2 variants display enhanced Spike-mediated fusion
- Rajah Maaran Michael; Hubert Mathieu; Bishop Elodie; Saunders Nell; Robinot Remy; Grzelak Ludivine; Planas Delphine; Zivaljic Marija; Planchais Cyril; Guivel-Benhassine Florence; Porrot Françoise; Mouquet Hugo; Chakrabarti Lisa; Buchrieser Julian; Schwartz Olivier; ; (, v., 2021, )
-
6
- CPX-351 Appears Superior to 7+3 in Adverse-Risk AML and AML-MRC
- Bouligny, Ian M.; Murray, Graeme; Tran, Valerie; Gor, Juhi; Hang, Yiwei; Alnimer, Yanal; Zacholski, Kyle; Venn, Chad; Maher, Keri; ; (Blood, v.140, 2022, pp.11745-11746)
-
7
- Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study
- Linka Kevin; Peirlinck Mathias; Schäfer Amelie; Tikenogullari Oguz Ziya; Goriely Alain; Kuhl Ellen; ; (, v., 2021, )
-
8
- ChAdOx1 nCoV-19 (AZD1222) protects against SARS-CoV-2 B.1.351 and B.1.1.7
- Fischer Robert; van Doremalen Neeltje; Adney Danielle; Yinda Claude; Port Julia; Holbrook Myndi; Schulz Jonathan; Williamson Brandi; Thomas Tina; Barbian Kent; Anzick Sarah; Ricklefs Stacy; Smith Brian; Long Dan; Martens Craig; Saturday Greg; de Wit Emmie; Gilbert Sarah; Lambe Teresa; Munster Vincent; ; (, v., 2021, )
-
9
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- Planas Delphine; Bruel Timothee; Grzelak Ludivine; Guivel-Benhassine Florence; Staropoli Isabelle; Porrot Francoise; Planchais Cyril; Buchrieser Julian; Rajah Maaran Michael; Bishop Elodie; Albert Melanie; Donati Flora; Behillil Sylvie; Enouf Vincent; Marianne Maquart; Gonzalez Maria; De Seze Jerome; Pere Helene; Veyer David; Seve Aymeric; Simon-Loriere Etienne; Fafi-Kremer Samira; Stefic Karl; Mouquet Hugo; Hocqueloux Laurent; van der Werf Sylvie; Prazuck Thierry; Schwartz Olivier; ; (, v., 2021, )
-
10
- Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
- Wang Pengfei; Liu Lihong; Iketani Sho; Luo Yang; Guo Yicheng; Wang Maple; Yu Jian; Zhang Baoshan; Kwong Peter D.; Graham Barney S.; Mascola John R.; Chang Jennifer Y.; Yin Michael T.; Sobieszczyk Magdalena; Kyratsous Christos A.; Shapiro Lawrence; Sheng Zizhang; Nair Manoj S.; Huang Yaoxing; Ho David D.; ; (, v., 2021, )
QUICK MENU
